On behalf of the COVAX Vaccine Safety Working group: After COVID-19 vaccines are introduced into countries, it will be vital to...

The current Brighton Collaboration Science Board has voted to accept all 16 candidates onto the new Brighton Collaboration Science...

SPEAC has completed a 4th update of the COVID-19 clinical literature covering the period from November 2020 – August 2021. Click...

We would like to announce the upcoming Brighton Collaboration Science Board election. The Science Board meets monthly for one hour...

As part of its role to support the assessment of safety of vaccines being evaluated in CEPI funded clinical trials, the Safety Pla...

Recent news of the possible complications of blood clots – or Thrombosis with Thrombocytopenia Syndrome (TTS) – following the...

 The Benefit-Risk Assessment of Vaccines by TechnolOgy (BRAVATO) working group has developed standardized templates for the col...

The Centers for Disease Control and Prevention (CDC) has invested in The Task Force for Global Health (TFGH) to help low and mid...

SPEAC has completed a second update of the COVID-19 clinical literature covering the period of August 8 through November 13th 202...

Robert Chen, the Scientific Director of Brighton Collaboration, discussed the safety profiles of COVID-19 vaccines with the Coali...